A clinical and molecular Phase II trial of oral ENMD-2076 in ovarian clear cell carcinoma (OCCC): A study of the Princess Margaret Phase II Consortium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Aug .
Lheureux Stephanie, Tinker Anna V, Clarke Blaise A, Ghatage Prafull, Welch Stephen, Weberpals Johanne I, Dhani Neesha C, Butler Marcus O, Tonkin Katia, Tan Qian, Tan David S P, Brooks Kelly, Ramsahai Janelle, Wang Lisa, Pham Nhu-An, Shaw Patricia A, Tsao Ming-Sound, Garg Swati, Stockley Tracy L, Oza Amit
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: